Allergan Aesthetics, an AbbVie company, has launched the Skin Quality Index, a standardized framework for assessing skin quality in aesthetics. The new index is intended to give patients and providers ...

AbbVie Inc. (NYSE:ABBV) is one of Goldman Sachs top healthcare stocks. On March 9, William Blair reiterated an Outperform rating on AbbVie Inc. (NYSE:ABBV). The research firm remains confident about ...

AbbVie Inc. (NYSE:ABBV) ranks among the 14 safe stocks to buy now for a starter stock portfolio. On February 24, RBC Capital began coverage of AbbVie Inc. (NYSE:ABBV) with an Outperform rating and a ...

AbbVie Inc. (NYSE:ABBV) is included among the 13 Undervalued Dividend Aristocrats to Buy Now. AbbVie Inc. (NYSE:ABBV) is a research-based biopharmaceutical company that engages in the research and ...

The MAD portion of the study enrolled a total of 76 participants.

AbbVie’s foray into the obesity space is successful so far, analysts agree, as amylin analog ABBV-295 elicited as much as 9.73% weight loss at 13 weeks in the multiple ascending dose portion of a ...

Dividend stocks can make for great long-term investments. They can generate a steady stream of income for your portfolio, not ...

The expansion is expected to create 300 new jobs, including positions for engineers, scientists, manufacturing operators and lab technicians.

The two new facilities will create 300 jobs and are part of the drugmaker’s broader plan to invest $100 billion in the U.S.

AbbVie Inc. ABBV shares are trading lower on Monday. The U.S. drug maker shared topline results from a Phase 1 study of ...

AbbVie loses bid to block Tennessee 340B law as federal court upholds state statute limiting drugmaker restrictions on contract pharmacies.

The company's ability to hold off generic competitors long enough to develop a pair of replacement drugs for Humira that are ...